{"DataElement":{"publicId":"6690687","version":"1","preferredName":"BRCA1 Gene Mutation Abnormality Cytogenetic Analysis Outcome Status","preferredDefinition":"The text response that indicates the type of BRCA1 variant identified as a result of mutational analysis.","longName":"BRCA1_MUT_ANA_OUT_ST","context":"OCG","contextVersion":"1","DataElementConcept":{"publicId":"6689662","version":"1","preferredName":"BRCA1 Gene Mutation Abnormality Cytogenetic Analysis Outcome","preferredDefinition":"This gene plays a role in cell cycle control, regulation of transcription and the maintenance of genomic stability. It is also involved in the inhibition of mammary cell growth._Any transmissible change in the genetic material of an organism, which can result from radiation, viral infection, transposition, treatment with mutagenic chemicals and errors during DNA replication or meiosis. The effects of mutation range from single base changes to loss or gain of complete chromosomes. As many of the simpler alterations to DNA may be repaired, such changes are only heritable once the change is fixed in the DNA by the process of replication. Mutations may be associated with genetic diversity or with pathologies including cancer._Techniques for analysis of chromosomal and subchromosomal properties and structures, such as those to diagnose, classify, screen for, or manage genetic diseases and abnormalities._The result of an action.","longName":"2262100v1.0:6689660v1.0","context":"OCG","contextVersion":"1","ObjectClass":{"publicId":"2262100","version":"1","preferredName":"BRCA1 Gene","preferredDefinition":"Tumor suppressor genes located on human chromosome 17q12-21. The mutation of these genes is associated with the formation of familial breast and ovarian cancer.","longName":"C17965","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"BRCA1 Gene","conceptCode":"C17965","definition":"This gene plays a role in cell cycle control, regulation of transcription and the maintenance of genomic stability. It is also involved in the inhibition of mammary cell growth.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"FC1FEFCA-4577-3CB3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-07-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-07-19","modifiedBy":"ONEDATA","dateModified":"2005-07-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"6689660","version":"1","preferredName":"Mutation Abnormality Cytogenetic Analysis Outcome","preferredDefinition":"Any transmissible change in the genetic material of an organism, which can result from radiation, viral infection, transposition, treatment with mutagenic chemicals and errors during DNA replication or meiosis. The effects of mutation range from single base changes to loss or gain of complete chromosomes. As many of the simpler alterations to DNA may be repaired, such changes are only heritable once the change is fixed in the DNA by the process of replication. Mutations may be associated with genetic diversity or with pathologies including cancer.:Techniques for analysis of chromosomal and subchromosomal properties and structures, such as those to diagnose, classify, screen for, or manage genetic diseases and abnormalities.:The result of an action.","longName":"C45576:C18280:C20200","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mutation Abnormality","conceptCode":"C45576","definition":"Any transmissible change in the genetic material of an organism, which can result from radiation, viral infection, transposition, treatment with mutagenic chemicals and errors during DNA replication or meiosis. The effects of mutation range from single base changes to loss or gain of complete chromosomes. As many of the simpler alterations to DNA may be repaired, such changes are only heritable once the change is fixed in the DNA by the process of replication. Mutations may be associated with genetic diversity or with pathologies including cancer.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Cytogenetic Analysis","conceptCode":"C18280","definition":"Techniques for analysis of chromosomal and subchromosomal properties and structures, such as those to diagnose, classify, screen for, or manage genetic diseases and abnormalities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Outcome","conceptCode":"C20200","definition":"The result of an action.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8633F08E-8427-3921-E053-F662850AAF2D","latestVersionIndicator":"Yes","beginDate":"2019-04-10","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-10","modifiedBy":"ONEDATA","dateModified":"2019-04-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8633F08E-8438-3921-E053-F662850AAF2D","latestVersionIndicator":"Yes","beginDate":"2019-04-10","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-10","modifiedBy":"HARTLEYG","dateModified":"2019-04-17","changeDescription":"Curated to support Ovarian content","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6689292","version":"1","preferredName":"Gene Mutation Analysis Status","preferredDefinition":"The result of an action._A condition or state at a particular time.","longName":"6689292v1.0","context":"OCG","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"60","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Variant of uncertain significance (VUS) (specify)","valueDescription":"Specify Variant of Unknown Significance","ValueMeaning":{"publicId":"6689293","version":"1","preferredName":"Specify Variant of Unknown Significance","longName":"6689293","preferredDefinition":"Be specific about something; define clearly.: A variation in a genetic sequence whose association with disease risk is unknown.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Specify","conceptCode":"C25685","definition":"Be specific about something; define clearly.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Variant of Unknown Significance","conceptCode":"C94187","definition":"An indication that there is not enough information to support a more definitive classification of the pathogenicity of a genetic variant.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8622C0E6-7591-729B-E053-F662850A7296","latestVersionIndicator":"Yes","beginDate":"2019-04-09","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-09","modifiedBy":"ONEDATA","dateModified":"2019-04-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8622C0E6-75AA-729B-E053-F662850A7296","beginDate":"2019-04-09","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-09","modifiedBy":"ONEDATA","dateModified":"2019-04-09","deletedIndicator":"No"},{"value":"Pathogenic variant (specify)","valueDescription":"Specify Pathogen Mutant Protein","ValueMeaning":{"publicId":"6689294","version":"1","preferredName":"Specify Pathogen Mutant Protein","longName":"6689294","preferredDefinition":"Be specific about something; define clearly.: An agent of disease; a disease producer.: A protein with an amino acid sequence that differs from the wildtype, canonical sequence.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Specify","conceptCode":"C25685","definition":"Be specific about something; define clearly.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Pathogen","conceptCode":"C80324","definition":"An agent of disease; a disease producer.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Mutant Protein","conceptCode":"C147118","definition":"A protein with an amino acid sequence that differs from the wildtype, canonical sequence.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8622C0E6-75B8-729B-E053-F662850A7296","latestVersionIndicator":"Yes","beginDate":"2019-04-09","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-09","modifiedBy":"ONEDATA","dateModified":"2019-04-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8622C0E6-75D1-729B-E053-F662850A7296","beginDate":"2019-04-09","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-09","modifiedBy":"ONEDATA","dateModified":"2019-04-09","deletedIndicator":"No"},{"value":"Benign variant","valueDescription":"Benign Mutant Protein","ValueMeaning":{"publicId":"6689295","version":"1","preferredName":"Benign Mutant Protein","longName":"6689295","preferredDefinition":"Not cancerous. Benign tumors may grow larger but do not spread to other parts of the body.: A protein with an amino acid sequence that differs from the wildtype, canonical sequence.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Benign","conceptCode":"C14172","definition":"For neoplasms, a non-infiltrating and non-metastasizing neoplastic process that is characterized by the absence of morphologic features associated with malignancy (e.g., severe atypia, nuclear pleomorphism, tumor cell necrosis, and abnormal mitoses). For other conditions, a process that is mild in nature and not dangerous to health.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Mutant Protein","conceptCode":"C147118","definition":"A protein with an amino acid sequence that differs from the wildtype, canonical sequence.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8622C0E6-75DE-729B-E053-F662850A7296","latestVersionIndicator":"Yes","beginDate":"2019-04-09","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-09","modifiedBy":"ONEDATA","dateModified":"2019-04-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8622C0E6-75F7-729B-E053-F662850A7296","beginDate":"2019-04-09","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-09","modifiedBy":"ONEDATA","dateModified":"2019-04-09","deletedIndicator":"No"},{"value":"No variant","valueDescription":"Negation Mutant Protein","ValueMeaning":{"publicId":"6689296","version":"1","preferredName":"Negation Mutant Protein","longName":"6689296","preferredDefinition":"An operation in which a term denies or inverts the meaning of another term or construction.: A protein with an amino acid sequence that differs from the wildtype, canonical sequence.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Negation","conceptCode":"C25594","definition":"An operation in which a term denies or inverts the meaning of another term or construction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Mutant Protein","conceptCode":"C147118","definition":"A protein with an amino acid sequence that differs from the wildtype, canonical sequence.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8622C0E6-7604-729B-E053-F662850A7296","latestVersionIndicator":"Yes","beginDate":"2019-04-09","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-09","modifiedBy":"ONEDATA","dateModified":"2019-04-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8622C0E6-761D-729B-E053-F662850A7296","beginDate":"2019-04-09","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-09","modifiedBy":"ONEDATA","dateModified":"2019-04-09","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2404650","version":"1","preferredName":"Status","preferredDefinition":"A condition or state at a particular time.","longName":"C25688","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Status","conceptCode":"C25688","definition":"A condition or state at a particular time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"005AD6E5-057F-6A35-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-09-09","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-09-09","modifiedBy":"ONEDATA","dateModified":"2005-09-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8622C0E6-7576-729B-E053-F662850A7296","latestVersionIndicator":"Yes","beginDate":"2019-04-09","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-09","modifiedBy":"HARTLEYG","dateModified":"2019-04-17","changeDescription":"Curated to support Ovarian content","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"5806857","version":"1","longName":"HCMI (Human Cancer Models Initiative)","context":"OCG","ClassificationSchemeItems":[{"publicId":"10000168","version":"1","longName":"Ovarian","context":"OCG"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"BRCA1 mutation analysis result","type":"Preferred Question Text","description":"BRCA1 mutation analysis result","url":null,"context":"OCG"}],"origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"864AE3A6-7B27-39FB-E053-F662850A55C7","latestVersionIndicator":"Yes","beginDate":"2019-04-11","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-11","modifiedBy":"COOPERM","dateModified":"2019-07-22","changeDescription":"Curated to support Ovarian content","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}